Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 13787
Country/Region: Zambia
Year: 2016
Main Partner: Churches Health Association of Zambia
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 207
HTS_TST Age/sex: 1-9 2017 825
HTS_TST Age/sex: 10-14 Female 2017 355
HTS_TST Age/sex: 10-14 Male 2017 1,305
HTS_TST Age/sex: 15-19 Female 2017 1,976
HTS_TST Age/sex: 15-19 Male 2017 1,615
HTS_TST Age/sex: 20-24 Female 2017 2,974
HTS_TST Age/sex: 20-24 Male 2017 2,449
HTS_TST Age/sex: 25-49 Female 2017 3,415
HTS_TST Age/sex: 25-49 Male 2017 3,377
HTS_TST Age/sex: 50+ Female 2017 1,154
HTS_TST Age/sex: 50+ Male 2017 1,072
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,205
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,907
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 9,249
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 8,363
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 20,724
HTS_TST Service Delivery Point (Facility): Inpatient 2017 9,012
HTS_TST Service Delivery Point (Facility): Outpatient 2017 3,166
HTS_TST Service Delivery Point (Facility): PMTCT 2017 2,833
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 36
HTS_TST Service Delivery Point (Facility): VCT 2017 4,514
HTS_TST Service Delivery Point (Facility): VMMC 2017 1,163
HTS_TST Sum of Age/Sex disaggregates 2017 19,692
HTS_TST Sum of Aggregated Age/Sex <15 2017 3,112
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 17,612
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 20,724
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 216
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 44
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 252
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 190
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 340
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 285
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 444
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 373
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 283
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 306
HTS_TST_POS Test Result by Age: Positive: <1 2017 24
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 264
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 485
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 55
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,282
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,199
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 1,858
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 1,858
KP_PREV Total estimated number of key population in the catchment area 2017 1,858
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 1,858
PMTCT_ART Already on ART at beginning of current pregnancy 2017 225
PMTCT_ART New on ART 2017 128
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 6,324
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 153
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 165
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 11
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 3
PMTCT_EID Sum of Infant Age disaggregates 2017 318
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 180
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 992
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 2,038
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 2,775
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 339
PMTCT_STAT By: Known positives at entry 2017 405
PMTCT_STAT By: Number of new positives identified 2017 355
PMTCT_STAT Number of new ANC and L&D clients 2017 6,324
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 6,324
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 6
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 32
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 122
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 194
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 51
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: <15 2017 5
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 31
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 95
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 157
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 67
PMTCT_STAT Sum of Positives Status disaggregates 2017 760
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 180
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 992
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 2,038
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 2,775
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 339
PP_PREV Aggregated Age/sex: <15 Female 2017 9,273
PP_PREV Aggregated Age/sex: <15 Male 2017 6,696
PP_PREV Aggregated Age/sex: 15+ Female 2017 21,478
PP_PREV Aggregated Age/sex: 15+ Male 2017 15,927
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 53,374
PP_PREV Total number of people in the target population 2017 53,374
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 11
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 261
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 14
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 243
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 529
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 529
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 26,047
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 28,152
TB_SCREENDX Screen Result: Screened Positive for TB 2017 26,047
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 14,144
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 10,704
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 764
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 435
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 26,047
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 8
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 267
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 13
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 260
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 548
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 548
TX_CURR Age/Sex: <1 2017 31
TX_CURR Age/Sex: <1-9 2017 98
TX_CURR Age/Sex: 10-14 Female 2017 2,541
TX_CURR Age/Sex: 10-14 Male 2017 2,176
TX_CURR Age/Sex: 15-19 Female 2017 3,796
TX_CURR Age/Sex: 15-19 Male 2017 3,914
TX_CURR Age/Sex: 20-24 Female 2017 4,408
TX_CURR Age/Sex: 20-24 Male 2017 3,576
TX_CURR Age/Sex: 25-49 Female 2017 6,096
TX_CURR Age/Sex: 25-49 Male 2017 7,312
TX_CURR Age/Sex: 50+ Female 2017 4,248
TX_CURR Age/Sex: 50+ Male 2017 3,260
TX_CURR Aggregated Age/Sex: <15 Female 2017 2,723
TX_CURR Aggregated Age/Sex: <15 Male 2017 2,419
TX_CURR Aggregated Age/Sex: 15+ Female 2017 19,140
TX_CURR Aggregated Age/Sex: 15+ Male 2017 17,174
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 41,456
TX_CURR Sum of age/sex disaggregates 2017 7,710
TX_CURR Sum of Aggregated Age/Sex <15 2017 5,142
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 36,314
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 41,456
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 227
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 234
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 2,848
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 2,717
TX_NEW By Age/Sex: <1 2017 69
TX_NEW By Age/Sex: 1-9 2017 219
TX_NEW By Age/Sex: 10-14 Female 2017 150
TX_NEW By Age/Sex: 10-14 Male 2017 135
TX_NEW By Age/Sex: 15-19 Female 2017 647
TX_NEW By Age/Sex: 15-19 Male 2017 681
TX_NEW By Age/Sex: 20-24 Female 2017 818
TX_NEW By Age/Sex: 20-24 Male 2017 873
TX_NEW By Age/Sex: 25-49 Female 2017 1,132
TX_NEW By Age/Sex: 25-49 Male 2017 1,053
TX_NEW By Age/Sex: 50+ Female 2017 154
TX_NEW By Age/Sex: 50+ Male 2017 95
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 6,026
TX_NEW Sum of Age/Sex disaggregates 2017 5,738
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 6,026
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 2,239
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 2,518
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 154
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 136
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 1,150
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 1,078
TX_PVLS Numerator: Indication: Targeted 2017 2,518
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 138
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 122
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 1,021
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 958
TX_PVLS_den Denominator: Indication: Targeted 2017 2,239
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 24
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 32
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 184
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 213
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 314
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 324
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 991
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,001
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,152
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,079
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 350
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 341
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 327
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 337
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,679
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,662
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 6,005
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 6,005
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 24
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 32
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 184
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 213
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 314
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 324
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 991
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,001
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,152
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,079
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 350
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 341
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 327
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 337
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,679
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,662
VMMC_CIRC By Age: 0-60 days 2017 15
VMMC_CIRC By Age: 10-14 2017 823
VMMC_CIRC By Age: 15-19 2017 1,280
VMMC_CIRC By Age: 2 months - 9 years 2017 44
VMMC_CIRC By Age: 20-24 2017 947
VMMC_CIRC By Age: 25-29 2017 516
VMMC_CIRC By Age: 30-49 2017 266
VMMC_CIRC By Age: 50+ 2017 31
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 3,922
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 3,922
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 3,863
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 3,081